The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-7-Cyclopropyl-N-(quinuclidin-3-yl)pyrrolo[1,2-a]quinoline-2-carboxamide ID: ALA4536365
PubChem CID: 155548230
Max Phase: Preclinical
Molecular Formula: C23H25N3O
Molecular Weight: 359.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(N[C@H]1CN2CCC1CC2)c1cc2ccc3cc(C4CC4)ccc3n2c1
Standard InChI: InChI=1S/C23H25N3O/c27-23(24-21-14-25-9-7-16(21)8-10-25)19-12-20-5-3-18-11-17(15-1-2-15)4-6-22(18)26(20)13-19/h3-6,11-13,15-16,21H,1-2,7-10,14H2,(H,24,27)/t21-/m0/s1
Standard InChI Key: KPFZLQPTZSESAS-NRFANRHFSA-N
Molfile:
RDKit 2D
27 32 0 0 0 0 0 0 0 0999 V2000
36.7519 -11.0660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4735 -11.4962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2063 -11.0821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7585 -10.2303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4843 -9.8180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2105 -10.2422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2175 -8.5650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4890 -8.9828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9443 -8.9915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9341 -9.8305 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.7300 -10.0973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2318 -9.4246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7465 -8.7401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0695 -9.4348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4817 -10.1681 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.4993 -8.7157 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.3195 -10.1783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.7253 -10.9143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5636 -10.9264 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.9930 -10.2092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5862 -9.4781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.7459 -9.4643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8571 -10.1819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.4308 -10.2685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0398 -11.4668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2235 -11.4595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6244 -12.1716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 10 1 0
9 7 1 0
7 8 2 0
8 5 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 9 2 0
12 14 1 0
14 15 1 0
14 16 2 0
17 15 1 6
17 18 1 0
17 22 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 19 1 0
1 25 1 0
26 25 1 0
27 26 1 0
25 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 359.47Molecular Weight (Monoisotopic): 359.1998AlogP: 3.79#Rotatable Bonds: 3Polar Surface Area: 36.75Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.91CX LogP: 2.86CX LogD: 2.23Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.77Np Likeness Score: -0.45
References 1. Xue Y, He X, Yang T, Wang Y, Liu Z, Zhang G, Wang Y, Wang K, Zhang L, Zhang L.. (2019) Discovery of fused heterocyclic carboxamide derivatives as novel α7-nAChR agonists: Synthesis, preliminary SAR and biological evaluation., 182 [PMID:31434041 ] [10.1016/j.ejmech.2019.111618 ]